Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

CONTEXT: For patients with metastatic papillary thyroid carcinoma (PTC) refractory to radioactive iodine (RAI) treatment, systemic chemotherapy has limited efficacy. Such tumors frequently harbor BRAF V600E, and this alteration may predict responsiveness to vemurafenib treatment. OBJECTIVE: We repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Siraj M., He, Je, Carson, Wade, Stephens, Phil J., Fiorillo, Joseph, Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Miller, Vincent A., Sharman, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: May, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067722/
https://www.ncbi.nlm.nih.gov/pubmed/24987354
http://dx.doi.org/10.1159/000363377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067722/
https://www.ncbi.nlm.nih.gov/pubmed/24987354
http://dx.doi.org/10.1159/000363377

Ejemplares similares